OTC office director
This article was originally published in The Tan Sheet
Executive Summary
Effective June 28, Michael Weintraub, MD, officially becomes director of FDA's Office of OTC Drug Evaluation. Weintraub had been an "FDA consultant" with responsibility for overseeing the OTC office since late 1991. Weintraub is being considered for one of two Center for Drug Evaluation and Research deputy director posts ("The Tan Sheet" June 28, In Brief)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning